Led by Dr. James M. Wilson, the Gene Therapy Program at the University of Pennsylvania (GTP) focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. GTP strives to develop and commercialize transformative genetic-based therapeutics driven by the unmet needs of patients with inherited genetic diseases.

Led by Dr. James M. Wilson, the Gene Therapy Program at the University of Pennsylvania (GTP) focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. GTP strives to develop and commercialize transformative genetic-based therapeutics driven by the unmet needs of patients with inherited genetic diseases.

Led by Dr. James M. Wilson, the Gene Therapy Program at the University of Pennsylvania (GTP) focuses on the development of next-generation gene transfer vectors and their application in the treatment of a variety of acquired and inherited diseases. GTP strives to develop and commercialize transformative genetic-based therapeutics driven by the unmet needs of patients with inherited genetic diseases.